CellTherapeutics, Stock Price 8,300 KRW (-3.94%)... Bulletin Board 'Bustling'

At this time, posts about Cellma Therapeutics are rapidly increasing on portals and securities communities, while foreign investors are tentatively estimated to have net purchased 15,239 shares today. Cellma Therapeutics is known as a company distributing gift certificate discounts and dental materials.

As of 11:30 AM on the 8th, the stock price of Cellma Therapeutics is 8,300 KRW, down 3.94% from the previous day, with a trading volume of 527,396 shares, which is about 44.68% of the 5-day average trading volume. On October 7th, Cellma Therapeutics became an issue in the market with the headline "Stock price plummets despite application for Phase 3 clinical trial of COVID-19 treatment."

In addition to Cellma Therapeutics, posts by investors are also rapidly increasing for Kwangdong Pharmaceutical (009290), Nara M&D (051490), and KPM Tech (042040).

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.